|
If you're having surgery, you want Haemacure to stick around. The company specializes in sealants and adhesives used in surgical procedures ranging from tonsillectomies to cardiovascular surgeries. The company is developing its own human tissue-based tissue glue called Hemaseel HMN, which is in clinical trials. A component, Hemaseel Thrombin, used to stop surface bleeding during surgery, is in the pre-clinical stage. Haemacure also offers the HemaSyst and HemaMyst delivery systems. The company is based in Canada but its subsidiary in Sarasota, Florida, handles sales and marketing, as well as clinical and regulatory matters. Haemacure is seeking financing or a buyer or merger opportunity.
|
| | | Contact Information | |
Address: |
2001 University St., Ste. 430
Montreal, Quebec H3A 2A6, Canada
| | Phone: | 514-282-3350 | | Fax: | 514-282-3358 |
|
| Financial
Highlights | | Fiscal Year End: | October | | Revenue (2008): | 0.10 M | | Revenue Growth (1 yr): | (-36.30%) | | Employees (2008): | 20 | | Employee Growth (1 yr): | 5.30% |
|
|
Key People
| | • |
Chairman and CEO:
Joseph Galli
| | • |
President and Director:
Marc Paquin
| | • |
Director Finance and Administration:
Lyne Paré
|
|
|
